NCT03383458

Brief Summary

This study will investigate if nivolumab will improve recurrence-free survival (RFS) compared to placebo in participants with HCC who have undergone complete resection or have achieved a complete response after local ablation, and who are at high risk of recurrence

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
545

participants targeted

Target at P75+ for phase_3 hepatocellular-carcinoma

Timeline
59mo left

Started Apr 2018

Longer than P75 for phase_3 hepatocellular-carcinoma

Geographic Reach
24 countries

177 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Apr 2018Feb 2031

First Submitted

Initial submission to the registry

December 21, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 26, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

April 18, 2018

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2026

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2031

Expected
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

7.9 years

First QC Date

December 21, 2017

Last Update Submit

November 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recurrence-free Survival (RFS)

    Up to 49 months

Secondary Outcomes (2)

  • Overall Survival (OS)

    Up to 7 years

  • Time to recurrence (TTR)

    Up to 49 months

Study Arms (2)

Arm A

EXPERIMENTAL
Biological: Nivolumab

Arm B

PLACEBO COMPARATOR
Other: Placebo

Interventions

NivolumabBIOLOGICAL

Specified dose on specified days

Also known as: Opdivo, BMS-936558
Arm A
PlaceboOTHER

specified dose on specified days

Arm B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants with a first diagnosis of HCC who have undergone a curative resection or ablation
  • Participants are eligible to enroll if they have non-viral related-HCC, or if they have HBV-HCC, or HCV-HCC
  • Child-Pugh Score 5 or 6
  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1

You may not qualify if:

  • Known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC
  • Any evidence of tumor metastasis or co-existing malignant disease
  • Participants previously receiving any prior therapy for HCC, including loco-regional therapies
  • Participants who have undergone a liver transplant or those who are in the waiting list for liver transplantation
  • Participants who have received a live/attenuated vaccine within 30 days of randomization (eg, varicella, zoster, yellow fever, rotavirus, oral polio and measles, mumps, rubella \[MMR\]).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (184)

Local Institution - 0081

Anniston, Alabama, 36207, United States

Location

Mayo Clinic in Arizona - Phoenix

Phoenix, Arizona, 85054, United States

Location

Arizona Oncology Associates, PC - HOPE

Tucson, Arizona, 85711, United States

Location

Local Institution - 0135

Los Angeles, California, 90095, United States

Location

Local Institution - 0088

Palo Alto, California, 94304, United States

Location

Local Institution - 0085

San Francisco, California, 94115, United States

Location

Local Institution - 0235

Aurora, Colorado, 80045, United States

Location

Local Institution - 0267

Miami, Florida, 33125, United States

Location

Sylvester Comprehensive Cancer Center/ UMHC

Miami, Florida, 33136, United States

Location

Local Institution - 0163

Tampa, Florida, 33612, United States

Location

Local Institution - 0009

Atlanta, Georgia, 30322, United States

Location

Local Institution - 0025

Westwood, Kansas, 66205, United States

Location

Local Institution - 0086

New Orleans, Louisiana, 70112, United States

Location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Minnesota Oncology Hematology, P.A.

Minneapolis, Minnesota, 55404, United States

Location

Local Institution - 0209

St Louis, Missouri, 63110, United States

Location

Local Institution - 0075

New York, New York, 10016, United States

Location

Local Institution - 0208

New York, New York, 10029, United States

Location

Local Institution - 0045

New York, New York, 10065, United States

Location

Local Institution - 0219

White Plains, New York, 10601, United States

Location

MetroHealth Medical Center

Cleveland, Ohio, 44109, United States

Location

Local Institution - 0206

Portland, Oregon, 97225, United States

Location

Local Institution - 0272

Austin, Texas, 78705, United States

Location

Local Institution - 0270

Dallas, Texas, 75246, United States

Location

Local Institution - 0156

Dallas, Texas, 75390, United States

Location

Local Institution - 0273

Tyler, Texas, 75702, United States

Location

McGuire VA Medical Center

Richmond, Virginia, 23249, United States

Location

Local Institution - 0154

Seattle, Washington, 98109, United States

Location

Local Institution - 0243

Gorriti, Buenos Aires, 5737, Argentina

Location

Local Institution - 0254

Pilar, Buenos Aires, 1629, Argentina

Location

Local Institution - 0244

Rosario, Santa Fe Province, 2000, Argentina

Location

Local Institution - 0239

Blacktown, New South Wales, 2148, Australia

Location

Local Institution - 0166

Camperdown, New South Wales, 2050, Australia

Location

Local Institution - 0141

Concord, New South Wales, 2139, Australia

Location

Local Institution - 0220

Herston, Queensland, 4029, Australia

Location

Local Institution - 0164

Adelaide, South Australia, 5000, Australia

Location

Local Institution - 0224

Heidelberg, Victoria, 3084, Australia

Location

Local Institution - 0124

Nedlands, Western Australia, 6009, Australia

Location

Local Institution - 0012

Graz, 8036, Austria

Location

Local Institution - 0003

Vienna, 1090, Austria

Location

Local Institution - 0001

Vienna, 1100, Austria

Location

Local Institution - 0033

Brussels, 1070, Belgium

Location

Local Institution - 0064

Brussels, 1200, Belgium

Location

Local Institution - 0068

Edegem, 2650, Belgium

Location

Local Institution - 0071

Ghent, 9000, Belgium

Location

Local Institution - 0108

Leuven, 3000, Belgium

Location

Local Institution - 0090

Belo Horizonte, Minas Gerais, 30130-090, Brazil

Location

Local Institution - 0275

Barretos, São Paulo, 14780-070, Brazil

Location

Local Institution - 0237

Cerqueira César, São Paulo, 01246-000, Brazil

Location

Local Institution

São José do Rio Preto, São Paulo, 15090-000, Brazil

Location

Local Institution

São Paulo, São Paulo, 08270-120, Brazil

Location

Local Institution - 0023

São Paulo, 01308-050, Brazil

Location

Local Institution - 0236

São Paulo, 01509-010, Brazil

Location

Local Institution

Calgary, Alberta, T2N 4Z6, Canada

Location

Local Institution - 0116

Edmonton, T6G 1Z2, Canada

Location

Local Institution - 0247

Viña del Mar, Región de Valparaíso, 2520598, Chile

Location

Local Institution - 0248

Santiago, Santiago Metropolitan, 0, Chile

Location

Local Institution - 0246

Santiago, Santiago Metropolitan, 7710007, Chile

Location

Local Institution - 0245

Santiago, Santiago Metropolitan, 8380420, Chile

Location

Local Institution - 0256

Bogotá, 0, Colombia

Location

Local Institution - 0057

Bobigny, 93000, France

Location

Local Institution - 0052

Brest, 29200, France

Location

CHU Estaing

Clermont-Ferrand, 63003, France

Location

Local Institution - 0046

Clichy, 92110, France

Location

Local Institution - 0061

Créteil, 94010, France

Location

Local Institution - 0013

Grenoble, 38043, France

Location

Local Institution - 0222

Lille, 59037, France

Location

Local Institution - 0051

Lyon, 69317, France

Location

Local Institution - 0043

Montpellier, 34295, France

Location

Local Institution - 0037

Nice, 06202, France

Location

Local Institution

Poitiers, 86021, France

Location

Local Institution - 0098

Reims, 51100, France

Location

Local Institution - 0212

Rennes, 35033, France

Location

Local Institution - 0044

Saint-Priest-en-Jarez, 42270, France

Location

Local Institution - 0011

Vandœuvre-lès-Nancy, 54511, France

Location

Local Institution - 0054

Villejuif, 94800, France

Location

Local Institution - 0024

Aachen, 52057, Germany

Location

Local Institution - 0258

Berlin, 13353, Germany

Location

Local Institution - 0020

Bonn, 53127, Germany

Location

Local Institution - 0050

Cologne, 50937, Germany

Location

Local Institution - 0026

Essen, 45147, Germany

Location

Local Institution - 0093

Frankfurt am Main, 60590, Germany

Location

Local Institution - 0040

Hanover, 30625, Germany

Location

Local Institution - 0019

Homburg, 66421, Germany

Location

Local Institution

Leipzig, 04103, Germany

Location

Local Institution - 0036

Magdeburg, 39104 Magdeburg, Germany

Location

Local Institution - 0048

Mainz, 55131, Germany

Location

Universitatsmedizin Mannheim

Mannheim, 68167, Germany

Location

Local Institution - 0096

München, 81377, Germany

Location

Local Institution - 0008

Tübingen, 72076, Germany

Location

Local Institution

Würzburg, 97078, Germany

Location

Local Institution - 0120

Hong Kong, 999077, Hong Kong

Location

Local Institution - 0076

Hong Kong, Hong Kong

Location

Local Institution - 0136

Messina, ME, 98125, Italy

Location

Local Institution - 0102

Bologna, 40138, Italy

Location

Local Institution - 0077

Florence, 50134, Italy

Location

Local Institution - 0104

Meldola, 47014, Italy

Location

Local Institution - 0091

Milan, 20133, Italy

Location

Local Institution

Modena, 41124, Italy

Location

Local Institution - 0134

Monserrato, 09042, Italy

Location

Local Institution - 0101

Napoli, 80131, Italy

Location

Local Institution - 0119

Napoli, 80131, Italy

Location

Local Institution - 0103

Padua, 35128, Italy

Location

Local Institution - 0125

Rome, 00168, Italy

Location

Local Institution - 0183

Kashiwa-shi, Chiba, 2778577, Japan

Location

Local Institution - 0201

Kurume-shi, Fukuoka, 8300011, Japan

Location

Local Institution - 0200

Sapporo, Hokkaido, 060-8648, Japan

Location

Local Institution - 0184

Sapporo, Hokkaido, 0600033, Japan

Location

Local Institution - 0216

Nishinomiya-shi, Hyōgo, 6638501, Japan

Location

Local Institution - 0257

Morioka, Iwate, 0208505, Japan

Location

Local Institution - 0202

Kumamoto, Kumamoto, 8608556, Japan

Location

Local Institution - 0203

Osaka, Osaka, 5438555, Japan

Location

Local Institution - 0198

Osaka, Osaka, 5458586, Japan

Location

Local Institution

Ōsaka-sayama, Osaka, 5898511, Japan

Location

Local Institution - 0214

Suita-shi, Osaka, 565-0871, Japan

Location

Local Institution - 0185

Tokushima, Tokushima, 770-8503, Japan

Location

Local Institution - 0215

Bunkyo-ku, Tokyo, 1138655, Japan

Location

Local Institution - 0196

Chuo-ku, Tokyo, 1040045, Japan

Location

Local Institution - 0182

Mitaka-shi, Tokyo, 181-8611, Japan

Location

Local Institution - 0210

Musashino-shi, Tokyo, 1808610, Japan

Location

Local Institution - 0186

Shinjuku-ku, Tokyo, 162-8655, Japan

Location

Local Institution - 0187

Chiba, 260-8677, Japan

Location

Local Institution - 0179

Hiroshima, 734-8551, Japan

Location

Local Institution - 0180

Ishikawa, 920-8641, Japan

Location

Local Institution - 0197

Kanagawa, 213-8587, Japan

Location

Local Institution - 0148

Cuauhtémoc, Durango, 06700, Mexico

Location

Local Institution - 0121

Monterrey, Nuevo León, 64000, Mexico

Location

Local Institution - 0264

Monterrey, Nuevo León, 64460, Mexico

Location

Local Institution - 0226

San Luis Potosí City, 78250, Mexico

Location

Local Institution - 0263

Maastricht, 6229 HX, Netherlands

Location

Local Institution - 0260

Utrecht, 3584CX, Netherlands

Location

Local Institution - 0240

Auckland, 1023, New Zealand

Location

Local Institution - 0231

San Juan, 00927, Puerto Rico

Location

Local Institution

Brasov, 500091, Romania

Location

Local Institution - 0078

Bucharest, 022328, Romania

Location

Local Institution - 0232

Cluj-Napoca, 400015, Romania

Location

Local Institution - 0242

Constanța, 900591, Romania

Location

Local Institution - 0074

Craiova, 200542, Romania

Location

Local Institution - 0070

Timișoara, 300166, Romania

Location

Local Institution - 0032

Saint Petersburg, Sankt-Peterburg, 198255, Russia

Location

Arkhangelsk Clinical Oncological Dispensary

Arkhangelsk, 163045, Russia

Location

Local Institution

Leningrad Region, 188663, Russia

Location

Local Institution - 0230

Moscow, 115478, Russia

Location

Local Institution - 0042

Singapore, 119228, Singapore

Location

Local Institution - 0067

Singapore, 169610, Singapore

Location

Local Institution - 0039

Singapore, 308433, Singapore

Location

Local Institution - 0191

Suwon, Gyeonggi-do, 16499, South Korea

Location

Local Institution - 0127

Seoul, Seoul-teukbyeolsi [Seoul], 06351, South Korea

Location

Local Institution - 0177

Daegu, 41944, South Korea

Location

Local Institution - 0190

Goyang-si, 10408, South Korea

Location

Local Institution - 0188

Gyeongsangnam-do, 50612, South Korea

Location

Local Institution - 0178

Jeollanam-do, 58128, South Korea

Location

Local Institution - 0169

Seongnam-si, 13620, South Korea

Location

Local Institution - 0128

Seoul, 03080, South Korea

Location

Local Institution - 0168

Seoul, 03722, South Korea

Location

Local Institution - 0167

Seoul, 05505, South Korea

Location

Local Institution - 0195

Seoul, 06591, South Korea

Location

Local Institution - 0189

Seoul, 08308, South Korea

Location

Local Institution - 0069

Barcelona, 08035, Spain

Location

Local Institution - 0031

Barcelona, 08036, Spain

Location

Local Institution - 0016

Córdoba, 14004, Spain

Location

Local Institution - 0072

Donostia / San Sebastian, 20014, Spain

Location

Local Institution - 0199

Madrid, 28007, Spain

Location

Local Institution - 0109

Madrid, 28046, Spain

Location

Local Institution - 0100

Pamplona, 31008, Spain

Location

Local Institution - 0010

Sabadell (Barcelona), 08208, Spain

Location

Local Institution - 0028

Seville, 41013, Spain

Location

Local Institution - 0082

Valencia, 46026, Spain

Location

Local Institution - 0097

Zaragoza, 50009, Spain

Location

Local Institution - 0131

Tainan, TNN, 704, Taiwan

Location

Local Institution - 0204

Kaohsiung City, 883, Taiwan

Location

Local Institution - 0130

Taichung, 40447, Taiwan

Location

Local Institution - 0140

Taichung, 40705, Taiwan

Location

Local Institution - 0174

Tainan, 736, Taiwan

Location

Local Institution - 0207

Taipei, 100, Taiwan

Location

Local Institution - 0173

Taipei, 105, Taiwan

Location

Local Institution - 0129

Taipei, 11217, Taiwan

Location

Local Institution - 0175

Taoyuan District, 333, Taiwan

Location

Local Institution - 0176

Yunlin, 632, Taiwan

Location

Local Institution - 0111

London, NW3 2QG, United Kingdom

Location

Local Institution - 0092

London, SE5 9RS, United Kingdom

Location

Local Institution - 0153

London, W12 0HS, United Kingdom

Location

Local Institution - 0114

Manchester, M20 4BX, United Kingdom

Location

Local Institution - 0142

Metropolitan Borough of Wirral, CH63 4JY, United Kingdom

Location

Related Links

MeSH Terms

Conditions

Carcinoma, HepatocellularLiver Neoplasms

Interventions

Nivolumab

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Intervention Hierarchy (Ancestors)

Antibodies, Monoclonal, HumanizedAntibodies, MonoclonalAntibodiesImmunoglobulinsImmunoproteinsBlood ProteinsProteinsAmino Acids, Peptides, and ProteinsSerum GlobulinsGlobulins

Study Officials

  • Bristol-Myers Squibb

    Bristol-Myers Squibb

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR
Expanded Access
Yes

Study Record Dates

First Submitted

December 21, 2017

First Posted

December 26, 2017

Study Start

April 18, 2018

Primary Completion

February 27, 2026

Study Completion (Estimated)

February 27, 2031

Last Updated

November 21, 2025

Record last verified: 2025-11

Locations